HRMY financials
Harmony Biosciences (HRMY) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
HRMY income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $868.45M | $670.11M | $208.47M | $158.69M | 2.71 |
| 2024 | $714.73M | $557.92M | $190.83M | $145.49M | 2.51 |
| 2023 | $582.02M | $460.79M | $192.03M | $128.85M | 2.13 |
| 2022 | $437.86M | $354.37M | $120.19M | $181.47M | 2.97 |
| 2021 | $305.44M | $249.92M | $87.53M | $34.60M | 0.58 |
| 2020 | $159.74M | $132.00M | $16.99M | -$36.94M | -1.10 |
- HRMY revenue was $868.45M in fiscal 2025, net income $158.69M.
Updated 2026-11-07 11:55 UTC